Lv1
60 积分 2024-07-19 加入
RBM39 promotes hepatocarcinogenesis by regulating RFX1’s alternative splicing and subsequent activation of integrin signaling pathway
2个月前
已完结
Mitigating Limited Data Challenges to Improve Artificial Intelligence Integration in Rare Disease Drug Development
3个月前
已关闭
The Pharmacokinetics, Metabolism, and Clearance Mechanisms of Ritlecitinib, a Janus Kinase 3 and Tyrosine-Protein Kinase Family Inhibitor, in Humans
5个月前
已完结
Vertex’s opioid-free drug for acute pain wins FDA approval
8个月前
已完结
皖公网安备34019202002308
